Showing 1 - 20 results of 25 for search 'Sylvain Choquet', query time: 0.06s
Refine Results
-
1
-
2
Successful treatment with adapted high dose methotrexate in a hemodialysis patient with primary central nervous system lymphoma: 100 mg/m2 seems sufficient by Justine Solignac, Laure Farnault, Thomas Robert, Raphaelle Fanciullino, Sylvain Choquet, Philippe Brunet, Geoffroy Venton, Mickaël Bobot
Published 2022-03-01
Article -
3
Successful treatment with adapted high dose methotrexate in a hemodialysis patient with primary central nervous system lymphoma: 100 mg/m2 seems sufficient by Justine Solignac, Laure Farnault, Thomas Robert, Raphaelle Fanciullino, Sylvain Choquet, Philippe Brunet, Geoffroy Venton, Mickaël Bobot
Published 2022-03-01
Article -
4
-
5
Fatigue visual analogue scale score correlates with quality of life in cancer patients receiving epoetin alfa (Sandoz) for chemotherapy-induced anaemia: The CIROCO study by Jerome Desramé, Nathalie Baize, Amélie Anota, Kamel Laribi, Laetitia Stefani, Salim Hjiej, Ekatérina Nabirotchkina, Laurent Zelek, Sylvain Choquet
Published 2023-01-01
Article -
6
Skewed T cell responses to Epstein-Barr virus in long-term asymptomatic kidney transplant recipients. by Cecilia Nakid-Cordero, Nadia Arzouk, Nicolas Gauthier, Nadine Tarantino, Martin Larsen, Sylvain Choquet, Sonia Burrel, Brigitte Autran, Vincent Vieillard, Amélie Guihot
Published 2019-01-01
Article -
7
CCNF (Cyclin F) as a Candidate Gene for Familial Hodgkin Lymphoma: Additional Evidence for the Importance of Mitotic Checkpoint Defects in Tumorigenesis by Elsa Khoury, Hiba Maalouf, Antonella Mendola, Simon Boutry, Alessandra Camboni, Vincenzo D’Angiolella, Sylvain Choquet, Judith Landman-Parker, Caroline Besson, Hélène A. Poirel, Nisha Limaye
Published 2023-12-01
Article -
8
Risk Factors of Progression in Low-tumor Burden Follicular Lymphoma Initially Managed by Watch and Wait in the Era of PET and Rituximab by Cyrielle Rodier, Lukshe Kanagaratnam, David Morland, Adélie Herbin, Amandine Durand, Adrien Chauchet, Sylvain Choquet, Philippe Colin, René Olivier Casasnovas, Eric Deconinck, François Godard, Alain Delmer, Cédric Rossi, Eric Durot
Published 2023-05-01
Article -
9
P1388: EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH ALLOGENEIC EBV-SPECIFIC T-CELL IMMUNOTHERAPY (TABELECLEUCEL) UNDER AN EXPANDED ACCESS PROGRAM IN EU... by Sylvain Choquet, Andrew Clark, Cécile Renard, Ben Uttenthal, Sridhar Chaganti, Ralf Ulrich Trappe, Patrizia Comoli, Xinyuan Duan, Baodong Xing, Charley Wu, Laurence Gamelin, Jan-Henrik Terwey, Anke Friedetzky, Daan Dierickx
Published 2023-08-01
Article -
10
P1390: NEW AND UPDATED RESULTS FROM A MULTICENTER OPEN-LABEL GLOBAL PHASE3 STUDY OF TAB-CEL FOR EBV+PTLD FOLLOWING HCT OR SOT AFTER FAILURE OF RITUXIMAB OR RITUXIMAB+CHEMOTHERAPY (... by Mahadeo Kris Michael, Baiocchi Robert, Beitinjaneh Amer, Chaganti Sridhar, Sylvain Choquet, Daan Dierickx, Dinavahi Rajani, Laurence Gamelin, Armin Ghobadi, Guzman-Becerra Norma, Joshi Manher, Mehta Aditi, Nikiforow Sarah, Reshef Ran, Ye Wei, Prockop Susan
Published 2023-08-01
Article -
11
Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies Therapies by Aude Jary, Stéphane Marot, Antoine Faycal, Sacha Leon, Sophie Sayon, Karen Zafilaza, Emna Ghidaoui, Stéphanie Nguyen Quoc, Safaa Nemlaghi, Sylvain Choquet, Martin Dres, Valérie Pourcher, Vincent Calvez, Helga Junot, Anne-Geneviève Marcelin, Cathia Soulié
Published 2022-01-01
Article -
12
Baseline 18F-FDG Metabolic Tumor Volume Predicts Response to Rituximab Induction in Post-transplant Lymphoproliferative Disorders: A Multi-institutional Retrospective Study by David Morland, Lukshe Kanagaratnam, Fabrice Hubelé, Elise Toussaint, Sylvain Choquet, Aurélie Kas, Pierre-Ambroise Caquot, Corinne Haioun, Emmanuel Itti, Stéphane Leprêtre, Pierre Decazes, Fontanet Bijou, Paul Schwartz, Caroline Jacquet, Adrien Chauchet, Julien Matuszak, Nassim Kamar, Pierre Payoux, K-VIROGREF Study Group*, Eric Durot
Published 2023-02-01
Article -
13
Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study by Sylvain Lamure, Rémy Duléry, Roberta Di Blasi, Adrien Chauchet, Cécile Laureana, Bénédicte Deau-Fischer, Bernard Drenou, Carole Soussain, Cédric Rossi, Nicolas Noël, Sylvain Choquet, Serge Bologna, Bertrand Joly, Milena Kohn, Sandra Malak, Guillemette Fouquet, Etienne Daguindau, Sophie Bernard, Catherine Thiéblemont, Guillaume Cartron, Karine Lacombe, Caroline Besson
Published 2020-10-01
Article -
14
P1146: TRANSFUSION NEEDS AFTER CD19 CAR T-CELLS FOR LARGE B-CELL LYMPHOMA: PREDICTIVE FACTORS AND IMPACT ON OUTCOME. A DESCAR-T STUDY. by Samuel Vic, Jean-Baptiste Thibert, Emmanuel Bachy, Guillaume Cartron, Thomas Gastinne, Ibrahim Yakoub-Agha, Fabien Le Bras, Kamal Bouabdallah, Fabien Despas, Jacques Olivier Bay, Marie-Thérèse Rubio, Mohamad Mohty, Rene Olivier Casasnovas, Sylvain Choquet, Cristina Castilla-Llorente, Stephanie Guidez, Michael Loschi, Blandine Guffroy, Sylvain Carras, Laurianne Drieu La Rochelle, Roch Houot
Published 2023-08-01
Article -
15
Clinical presentation, outcome, and prognostic markers in patients with intravascular large B‐cell lymphoma, a lymphoma study association (LYSA) retrospective study by Antoine Bonnet, Céline Bossard, Ludovic Gabellier, Julien Rohmer, Othman Laghmari, Marie Parrens, Clémentine Sarkozy, Rémy Dulery, Virginie Roland, Francisco Llamas‐Gutierrez, Lucie Oberic, Luc‐Matthieu Fornecker, Laura Bounaix, Bruno Villemagne, Vanessa Szablewski, Sylvain Choquet, Krimo Bouabdallah, Alexandra Traverse‐Glehen, Mohamad Mohty, Laurence Sanhes, Roch Houot, Thomas Gastinne, Christophe Leux, Steven Le Gouill
Published 2022-10-01
Article -
16
S232: EFFICACY AND TOXICITY OF CAR-T CELLS IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS, A NEW REFERENCE: THE FRENCH EXPERIENCE OF THE NATIONAL LOC NETWORK by Sylvain Choquet, Carole Soussain, Magali Legarff-Tavernier, Roberta DI Blasi, Laetitia Souchet, Damien Roos-Weil, Veronique Morel Malek, Madalina Uzunov, Carole Metz, Stéphanie Nguyen-Quoc, Nicolas Gauthier, Lise Willems, Agathe Waultier Rascalou, Celia Salanoubat, Roch Houot, Renata Ursu, Lionel Galicier, Maryline Barrie, Guido Ahle, Blandine Guffroy, Marion Alcantara, Khe Hoang-Xuan, Caroline Houillier
Published 2023-08-01
Article -
17
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM) by Marion Detroit, Mathis Collier, Nathanaël Beeker, Lise Willems, Justine Decroocq, Bénédicte Deau-Fischer, Marguerite Vignon, Rudy Birsen, Frederique Moufle, Clément Leclaire, Elisabeth Balladur, Paul Deschamps, Adrien Chauchet, Rui Batista, Samuel Limat, Jean-Marc Treluyer, Laure Ricard, Nicolas Stocker, Olivier Hermine, Sylvain Choquet, Véronique Morel, Carole Metz, Didier Bouscary, Marie Kroemer, Jérémie Zerbit
Published 2023-08-01
Article -
18
Gain of the short arm of chromosome 2 (2p gain) has a significant role in drug‐resistant chronic lymphocytic leukemia by Fotini Kostopoulou, Clementine Gabillaud, Elise Chapiro, Beatrice Grange, Julie Tran, Simon Bouzy, Michael Degaud, Hussein Ghamlouch, Magali Le Garff‐Tavernier, Karim Maloum, Sylvain Choquet, Veronique Leblond, Jean Gabarre, Anne Lavaud, Veronique Morel, Damien Roos‐Weil, Madalina Uzunov, Romain Guieze, Olivier A. Bernard, Santos A. Susin, Olivier Tournilhac, Florence Nguyen‐Khac, the French Innovative Leukemia Organization (FILO) group
Published 2019-06-01
Article -
19
Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer by Marine Baron, Cathia Soulié, Armelle Lavolé, Lambert Assoumou, Baptiste Abbar, Baptiste Fouquet, Alice Rousseau, Marianne Veyri, Assia Samri, Alain Makinson, Sylvain Choquet, Julien Mazières, Solenn Brosseau, Brigitte Autran, Dominique Costagliola, Christine Katlama, Jacques Cadranel, Anne-Geneviève Marcelin, Olivier Lambotte, Jean-Philippe Spano, Amélie Guihot, The French Cooperative Thoracic Intergroup (IFCT) CHIVA-2 Investigators, The ANRS Co 24 OncoVIHAC Study Group
Published 2022-03-01
Article -
20
S233: AXICABTAGENE CILOLEUCEL AS SECOND-LINE THERAPY FOR LARGE B-CELL LYMPHOMA IN TRANSPLANT-INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY by Roch Houot, Emmanuel Bachy, Guillaume Cartron, Francois-Xavier Gros, Franck Morschhauser, Lucie Oberic, Thomas Gastinne, Pierre Feugier, Rémy Duléry, Catherine Thieblemont, Magalie Joris, Fabrice Jardin, Sylvain Choquet, Rene Olivier Casasnovas, Gabriel Brisou, Morgane Cheminant, Jacques Olivier Bay, Francisco Llamas, Cedric Menard, Karin Tarte, Marie-Helene Delfau-Larue, Emmanuel Itti, Clément Bailly, Yassine Al Tabaa, Camille Laurent, Francois Lemonnier
Published 2023-08-01
Article